Malaysia Drug Regulators See Harmonization As Long-term Plus For Domestic Industry

Malaysia’s National Pharmaceutical Control Board sees harmonization as opening doors for investment and local manufacturers to gain markets regionally and abroad.

More from Focus On Asia

More from Scrip